Skip to content

Bone Health Management for Women Diagnosed With Breast Cancer

Bone Health Management for Women Diagnosed With Breast Cancer: A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02484131
Enrollment
54
Registered
2015-06-29
Start date
2015-11-30
Completion date
2017-03-20
Last updated
2017-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Osteoporosis

Keywords

Osteoporosis, DXA Screening, Women, Breast Cancer, Survivors, Educational materials, Personal choices on delivery methods

Brief summary

The purpose of this study is to test the feasibility of the study protocol. The study protocol was designed to evaluate questions - Do educational materials improve dual x-ray absorptiometry (DXA) screening rates for women diagnosed with breast cancer and Does educational materials delivered by the participant's selected choice change DXA screening rates compared to the conventional mail method?.

Detailed description

Bone health management for osteoporosis is important for women diagnosed with breast cancer. Osteoporosis can lead to bones breaking easily. Broken bones may make living independently challenging. Effective bone health management can reduce the risk of broken bones. This study will examine whether providing osteoporosis information to women diagnosed with breast cancer will promote their bone health management. With the current advance in technology, people are more interested in receiving information by email or smartphone text messaging. This study will also examine whether delivering osteoporosis information in different ways will change bone health management.

Interventions

BEHAVIORALEducational materials/mail

Participants in this group will receive any educational materials by mail during hte follow-up period.

BEHAVIORALEducational materials/participant choice

Participants in this group will not receive any educational materials by participant choice during hte follow-up period.

Sponsors

British Columbia Cancer Agency
CollaboratorOTHER
University of British Columbia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Masking description

data analyst

Eligibility

Sex/Gender
FEMALE
Age
65 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Women * Is 65-75 year old on July 1st, 2015 * Lives in British Columbia (BC), Canada * Reads and understands the information provided in English * Was diagnosed with breast cancer prior to July 1st, 2012 * Is not receiving surgery, radiation or chemotherapy for any cancers * Has not had breast cancer spread beyond her breast(s) and nearby lymph nodes * Has not had screening tests after July 1st, 2012 * Is not taking medications prescribed by doctors for osteoporosis

Exclusion criteria

* Is medically unfit for preventive care (death, cognitive impairment, nursing home admission, severe mental illness, etc), which will be determined by their family doctors * Have terminated patient-doctor relationship with her family doctor who is indicated in our record

Design outcomes

Primary

MeasureTime frame
DXA screening rates6 months

Secondary

MeasureTime frameDescription
Percentage of participants diagnosed with osteoporosis6 months
Percentage of participants initiating osteoporosis medication6 months
Changes in Calcium in take6 monthsmeasured as mg per week using validated questionnaires
Changes in vitamin D status6 monthsmeasured as scores using validated questionnaires
Changes in exercise patterns6 monthsmeasured as scores using validated questionnaires

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026